Cytochrome b5 is a major reductant in vivo of human indoleamine 2,3-dioxygenase expressed in yeast

FEBS Letters

Volumn 580, Issue 9, 2006, Pages 2265-2268

  Vottero, Eduardo ^a   Mitchell, David A ^a   Page, Michael J ^a   MacGillivray, Ross T A ^a   Sadowski, Ivan J ^a   Roberge, Michel ^a   Mauk, A Grant ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Autoxidation; Cytochrome b5; Electron transfer; Indoleamine 2,3 dioxygenase; Yeast growth

Indexed keywords

CYTOCHROME B5; CYTOCHROME B5 REDUCTASE; INDOLEAMINE 2,3 DIOXYGENASE;

ARTICLE; GASTROPOD; IN VIVO STUDY; KNOCKOUT GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; YEAST;

CYTOCHROME-B(5) REDUCTASE; GENE EXPRESSION; HEME; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MUTATION; OXIDATION-REDUCTION; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS;

GASTROPODA;

EID: 33645977831     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.03.034     Document Type: Article

References (19)

1. Stone T.W. Kynurenic acid antagonists and kynurenine pathway inhibitors. Expert Opin. Investig. Drugs 10 (2001) 633-645
2. Muller A.J., DuHadaway J.B., Donover P.S., Sutanto-Ward E., and Prendergast G.C. Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat. Med. 11 (2005) 312-319
3. Widner B., Leblhuber F., Walli J., Tilz G.P., Demel U., and Fuchs D. Degradation of tryptophan in neurodegenerative disorders. Adv. Exp. Med. Biol. 467 (1999) 133-138
4. Wichers M.C., and Maes M. The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression. J. Psychiatry Neurosci. 29 (2004) 11-17
5. Takikawa O., Truscott R.J., Fukao M., and Miwa S. Age-related nuclear cataract and indoleamine 2,3-dioxygenase-initiated tryptophan metabolism in the human lens. Adv. Exp. Med. Biol. 527 (2003) 277-285
6. Hirata F., and Hayaishi O. Studies on indoleamine 2,3-dioxygenase. I. Superoxide anion as substrate. J. Biol. Chem. 250 (1975) 5960-5966
7. - complex. J. Biol. Chem. 252 (1977) 4637-4642
8. Dawson J.H. Probing structure-function relations in heme-containing oxygenases and peroxidases. Science 240 (1988) 433-439
9. Suzuki T., Kawamichi H., and Imai K. A myoglobin evolved from indoleamine 2,3-dioxygenase, a tryptophan-degrading enzyme. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 121 (1998) 117-128
10. Sono M., Roach M.P., Coulter E.D., and Dawson J.H. Heme-containing oxygenases. Chem. Rev. 96 (1996) 2841-2888
11. Shikama K. The molecular mechanism of autoxidation for myoglobin and hemoglobin: a venerable puzzle. Chem. Rev. 98 (1998) 1357-1374
12. Eder H.A., Finch C., and McKee R.W. Congenital methemoglobinemia. A clinical and biochemical study of a case. J. Clin. Invest. 28 (1949) 265-272
13. 5 reductase. Nat. New Biol. 229 (1971) 252-254
14. Vottero E., Balgi A., Woods K., Tugendreich S., Melese T., Andersen R.J., Mauk A.G., and Roberge M. Inhibitors of human indoleamine 2,3-dioxygenase identified with a target-based screen in yeast. Biotechnol. J. 1 (2006) 282-288
15. 5 reductase complex efficiently drives the entire sterol 14-demethylation (CYP51) reaction. FEBS Lett. 462 (1999) 283-288
16. Burke D., Dawson D., and Stearns T. Methods in Yeast Genetics (2000), Cold Spring Harbor Laboratory Press, Plainview, NY
17. Alani E., Cao L., and Kleckner N. A method for gene disruption that allows repeated use of URA3 selection in the construction of multiply disrupted yeast strains. Genetics 116 (1987) 541-545
18. Edgell C.J., McDonald C.C., and Graham J.B. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. USA 80 (1983) 3734-3737
19. 5 in reconstituted monooxygenase systems containing various forms of hepatic microsomal cytochrome P-450. J. Biochem. (Tokyo) 89 (1981) 351-362